FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39360411000001104: Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
115191000001110 Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
115201000001112 Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Is a Fluticasone 125micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Is a Sereflo true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) 120 dose Has AMP True Sereflo 25micrograms/dose / 125micrograms/dose inhaler (Pilsco Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start